2 Apr 2012 17:59
Press Release
For immediate release
2 April 2012
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Total voting rights
In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 31 March 2012 was 246,928,117 (excluding treasury shares)with each share holding one voting right.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.
The Company also holds 16,717,663 ordinary shares in treasury.
End
For further information please contact:
MedicX Group +44 (0) 1483 869 500
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
Canaccord Genuity Limited +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan Communications +44 (0) 20 7466 5000
Charles Ryland/Suzanne Brocks
MedicX Fund Limited +44 (0) 1481 723 450
David Staples, Chairman
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 71 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 27 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.